If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
There is no information on the use of tirzepatide in combination with NPH insulins or premixed insulins because this combination has not been studied.
Date of Last Review: February 05, 2021